27,149 Shares in Centene Corporation $CNC Acquired by J. Safra Sarasin Holding AG

J. Safra Sarasin Holding AG bought a new position in shares of Centene Corporation (NYSE:CNC) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 27,149 shares of the company’s stock, valued at approximately $1,117,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CNC. Addison Advisors LLC increased its position in Centene by 455.6% in the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after acquiring an additional 606 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new position in shares of Centene during the third quarter valued at $27,000. WPG Advisers LLC lifted its position in Centene by 44.5% during the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after purchasing an additional 282 shares during the period. Bogart Wealth LLC boosted its stake in Centene by 11,011.1% in the third quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock valued at $36,000 after acquiring an additional 991 shares during the last quarter. Finally, Ameriflex Group Inc. boosted its position in shares of Centene by 152.5% in the 3rd quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock worth $36,000 after purchasing an additional 610 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on CNC shares. Argus raised shares of Centene to a “hold” rating in a research note on Monday, February 9th. Morgan Stanley increased their target price on Centene from $38.00 to $45.00 and gave the stock an “equal weight” rating in a research note on Wednesday, March 4th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $41.00 price objective on shares of Centene in a research report on Monday, February 9th. Robert W. Baird boosted their target price on Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Centene from $32.00 to $39.00 and gave the stock a “hold” rating in a research report on Tuesday, February 10th. Three equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $41.81.

Centene Stock Performance

NYSE CNC opened at $33.99 on Thursday. Centene Corporation has a 52-week low of $25.08 and a 52-week high of $66.03. The stock has a market cap of $16.71 billion, a PE ratio of -2.50, a P/E/G ratio of 0.72 and a beta of 0.59. The firm has a 50-day moving average of $39.62 and a 200-day moving average of $38.72. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.10 and a current ratio of 1.10.

Centene (NYSE:CNC) last announced its earnings results on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The company had revenue of $49.73 billion for the quarter, compared to analyst estimates of $48.41 billion. During the same quarter last year, the company earned $0.80 earnings per share. The firm’s quarterly revenue was up 21.9% compared to the same quarter last year. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, sell-side analysts anticipate that Centene Corporation will post 6.86 EPS for the current year.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.